Table 3 Summary for decision-making in different pathologies during phase 3
From: A tentative guide for thoracic surgeons during COVID-19 pandemic
Pathology | What to operate | What to defer |
|---|---|---|
NSCLC | • Threatened airway • Tumor-associated severe infection • Hemodynamically unstable patients with tumor-associated hemorrhage | As phase 1, 2 plus hemodynamically stable patients with any complication |
Esophageal cancer | Septic perforation | As phase 1, 2 plus non-septic perforation |
Postoperative complications | Only hemodynamically unstable patients, critically compromised airway as active bleeding not amenable to nonsurgical management, dehiscence of airway, and anastomotic leak with sepsis. | As phase 2 plus any complication not critically compromising the airway or causing hemodynamic instability |
Trauma | All emergency cases as massive hemothorax, major airway injury, airway obstruction by inhaled foreign body or advanced tracheal stenosis, and diaphragmatic hernia with strangulation | As phase 2 plus any complication not critically compromising the airway or causing hemodynamic instability |